Google Scholar: cites
Drug therapy and catheter ablation for management of arrhythmias in continuous flow left ventricular assist device's patients : a Clinical Consensus Statement of the European Heart Rhythm Association and the Heart Failure Association of the ESC
Peichl, Petr (IKEM, Vídeňská 1958/9 (Praga, República Txeca))
Bayés-Genís, Antoni (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol)
Deneke, Thomas (University Hospital of the Paracelsus Medical University (Nuernberg, Alemanya))
Chioncel, O. (University of Medicine Carol Davila (Bucharest, Romania))
deRiva, Marta (Leiden University Medical Center)
Crespo-Leiro, Maria Generosa (Universidade da Coruña)
Frontera, Antonio (Great Metropolitan Hospital Niguarda)
Gustafsson, Finn (Rigshospitalet (Holanda))
Martins, Raphaël P. (University Hospital of Rennes)
Pagnesi, Matteo (University of Brescia)
Maury, Philippe (Rangueil Hospital of Toulouse)
Petrie, Mark (University of Glasgow)
Sacher, Frederic (University of Bordeaux)
Amir, Offer (Hadassah Medical Center and Hebrew University (Jerusalem, Israel))
Di Biase, Luigi (Albert Einstein College of Medicine (Nova York, Estats Units d'Amèrica))
Deisenhofer, Isabel (Technical University of Munich)
Alessio Gasparetti, Alessio (Johns Hopkins University (Baltimore, Estats Units d'Amèrica))
Moscoso Costa, Francisco (Hospital de Santa Cruz (Carnaxide, Portugal))
Brenda Moura, Brenda (Armed Forces Hospital (Portugal))
Skouri, Hadi (Balamand University (Beirut-Lebanon, Emirats Àrabs Units))
Gabriele Tocchetti, Carlo (Sheikh Shakhbout Medical City Abu Dhabi)
Volterrani, Maurizio (Università degli studi di Napoli Federico II)
Wakili, Reza (University Hospital of Frankfurt (Alemanya))

Data: 2024
Resum: Left ventricular assist devices (LVADs) are an increasingly used strategy for the management of patients with advanced heart failure. Although these devices effectively improve survival, atrial and ventricular arrhythmias are common with a prevalence of 20-50% at one year after LVAD implantation. Arrhythmias predispose these patients to additional risk and are associated with considerable morbidity from recurrent implantable cardioverter-defibrillator shocks, progressive failure of the unsupported right ventricle, and herald an increased risk of mortality. Management of patients with arrhythmias and LVAD differs in many aspects from the general population heart failure patients. These include ruling out the reversible causes of arrhythmias that in LVAD patients may include mechanical irritation from the inflow cannula and suction events. For patients with symptomatic arrhythmias refractory to medical treatment, catheter ablation might be relevant. There are specific technical and procedural challenges perceived to be unique to LVAD-related ventricular tachycardia (VT) ablation such as vascular and LV access, signal filtering, catheter manoeuvrability within decompressed chambers, and electroanatomic mapping system interference. In some patients, the arrhythmogenic substrate might not be readily accessible by catheter ablation after LVAD implantation. In this regard, the peri-implantation period offers a unique opportunity to surgically address arrhythmogenic substrate and suppress future VT recurrences. This document aims to address specific aspects of the management of arrhythmias in LVAD patients focusing on anti-arrhythmic drug therapy and ablations.
Drets: Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, la comunicació pública de l'obra i la creació d'obres derivades, fins i tot amb finalitats comercials, sempre i quan es reconegui l'autoria de l'obra original. Creative Commons
Llengua: Anglès
Document: Article ; recerca ; Versió publicada
Publicat a: Europace, Vol. 26 Núm. 11 (january 2024) , p. euae272, ISSN 1532-2092

DOI: 10.1093/europace/euae272
PMID: 39478667


16 p, 9.6 MB

El registre apareix a les col·leccions:
Documents de recerca > Documents dels grups de recerca de la UAB > Centres i grups de recerca (producció científica) > Ciències de la salut i biociències > Institut d'Investigació en Ciencies de la Salut Germans Trias i Pujol (IGTP)
Articles > Articles de recerca
Articles > Articles publicats

 Registre creat el 2025-04-30, darrera modificació el 2025-12-13



   Favorit i Compartir